Therapeutic Areas

Infectious Disease Clinical Trial and Regulatory Expertise

Rapidly advance your infectious disease vaccine or therapy to market.

Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.  In addition to recent pandemic outbreaks caused by viral infections, more treatment-resistant bacterial and fungal infections are increasing.  

If your goal is to mitigate emerging threats and advance human health, you need thoughtful planning and conduct for successful clinical development. Veristat’s scientific-minded infectious disease experts are devoted to helping you navigate this critical and challenging landscape. In the past 5 years, our global operations teams have conducted over 150 clinical trials and consulting projects for Infectious Disease treatments and vaccines  

Developing an infectious disease therapy or vaccine?   Let’s Talk.   

Infectious Disease Experience in the Past 5 Years

+0

Infectious Disease clinical trials and consulting projects

0%

are Biologics

0%

of global operations team members have infectious disease experience

Rapid Development of Vaccines and Therapies for Infections

Whether you aim to prevent or combat a viral, bacterial, fungal, or parasitic infection, Veristat global clinical trial and consulting experts can make a difference in your study’s success. Our teams understand the nuances and difficulties involved with treating infectious diseases, have deep experience executing vaccine trials, and are adept with  rapid response to global pandemicsthat arise, such as the recent COVID-19 response. 

Veristat scientific experts are poised to help:

Case Study: Collaboration for a Successful COVID-19 Vaccine Program


Learn how Veristat supported HIPRA, a European multinational pharmaceutical company, with a full range of clinical trial services that culminated in EMA approval for HIPRA’s BIMERVAX® COVID-19 vaccine. Having specialized in veterinary vaccines over its 50 years, HIPRA relied on Veristat’s extensive human vaccine experience to help the company swiftly progress through its clinical trials.

HubDB_Card Image_CS_HIPRA COVID

READ CASE STUDY

Scientific Knowledge Across a Broad Range of Infectious Agents

Viral Infections

  • Coronaviruses 
    Influenza 
    Hepatitis (A,B & C) 
    Human Papilloma Virus 
    Res Syncytial Virus (RSV) 
    West Nile Virus 
    and more… 

therapies and biologics to treat viral infections

Bacterial Infections

  • Clostridium Difficile  
    Botulinum 
    H.Pylori 
    Staphylococcus Aureus 
    Vacomycin-Resistant Enterococcal Infections 
    and more… 
therapies and biologics to treat bacterial infections

Fungal/Parasite Infections

  • Candidiasis 
    Invasive Fungal Infections 
    Onychomycosis 
    Onchoceriastis 
    Vaginosis 
    Scabies 
    and more... 
therapies and biologics for fungal and parasite infections
“We look forward to continuing our collaboration with Veristat as we bring two topical products into phase 2 trials later this year. We trust that the Veristat team will continue to help us accelerate our antifungal programs through development.”​
Mid-Size Biotech
Chief Medical Officer

Viral Infections 

  • Coronaviruses 
  • Influenza 
  • Hepatitis (A,B &C) 
  • Human Papilloma Virus 
  • Respiratory Syncytial Virus (RSV) 
  • West Nile Virus 
  • Yellow Fever 
  • And more… 
therapeutic_Respiratory_image12

Bacterial Infections

  • Clostridium Difficile  
  • Botulinum 
  • Intra-Abdonimal Infections 
  • H.Pylori 
  • Staphylococcus Aureus (including MRSA) 
  • Urinary Tract Infections 
  • Vacomycin-Resistant Enterococcal Infections 
  • And more… 
lab_cmc_nurseppehandstop

Fungal/Parasite Infections 

  • Candidiasis 
    Invasive Fungal Infections 
    Onychomycosis 
    Onchoceriastis 
    Vaginosis 
    Scabies 
    And more... 
dermatology_fungal Image_opt600px

Find out how our clinical trial and regulatory experts can help with your next study or program.

LET'S TALK

Learn More with These Resources

Conference Poster

Vaccine Clinical Trial Showcase: Phase 2b HIPRA Study Against ...

Published Article

How Vaccine Clinical Trials Work?

Case Study

Study Collaboration for Successful COVID-19 Vaccine Program